dyspepsia. Indigestion
Conditions
Interventions
Intervention 1: Group 1 : In during 12-13th days of PPI treatment , urease breath test is done with coadministration 4g of citric acid and in during 14-15th days it's done without administration of ci
Diagnosis
Group 1 : In during 12-13th days of PPI treatment , urease breath test is done with coadministration 4g of citric acid and in during 14-15th days it's done without administration of citric acid .
Group 2 : In during 12-13th days of PPI treatment , urease breath test is done without administration of citric acid and in during 14-15th days it's done with administration of 4g of citric acid .
Sponsors
Bidar Taban Ariya (BTA)
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age = 18 years ; Signed a consent form ; Detection of Helicobacter pylori infection ; start treatment with PPI Exclusion criteria: The history of previous gastric surgery ; Antibiotics consumption during 4 weeks before the first UBT test or during the study period ; Participation in a clinical study during 30 days before the screening visit ; Other considerable clinical disorders that researcher postulates patient is not eligible Taking H2 blocker or PPI ; 2 weeks before the study, Pregnancy ; History of recent peptic ulcer and esophagitis ; Prior therapy ; History of chronic liver and renal disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urease breath test with administration 4g of citric acid. Timepoint: 2 days. Method of measurement: UBT.;Urease breath test without administration 4g of citric acid. Timepoint: 2 days. Method of measurement: UBT. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarahnaz Joukar
Gastrointestinal and Liver Disease Research Center(GLDRC)
Outcome results
None listed